<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Dysregulation of the WNT/Î²-catenin (CTNNB1) signaling pathway is implicated in colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> and <z:e sem="disease" ids="C0025517" disease_type="Disease or Syndrome" abbrv="">metabolic diseases</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Considering these roles and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> prevention, we hypothesized that <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> CTNNB1 status might influence cellular sensitivity to <z:hpo ids='HP_0001513'>obesity</z:hpo> and physical activity </plain></SENT>
<SENT sid="2" pm="."><plain>In clinical follow-up of 109,046 women in the Nurses' Health Study and 47,684 men in the Health Professionals Follow-up Study, there were 861 incident rectal and <z:hpo ids='HP_0003003'>colon cancers</z:hpo> with tissue immunohistochemistry data on nuclear CTNNB1 expression </plain></SENT>
<SENT sid="3" pm="."><plain>Using this molecular pathological epidemiology database, we conducted Cox proportional hazards regression analysis using data duplication method to assess differential associations of body mass index (BMI) or exercise activity with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> risk according to <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> CTNNB1 status </plain></SENT>
<SENT sid="4" pm="."><plain>Greater BMI was associated with a significantly higher risk of CTNNB1-negative <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> [multivariate HR = 1.34; 95% confidence interval (CI), 1.18-1.53 for 5.0 kg/m increment; P = 0.0001] but not with CTNNB1-positive <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> risk (multivariate HR = 1.07; 95% CI, 0.92-1.25 for 5.0 kg/m increment; P = 0.36; P = 0.027, between CTNNB1-negative and CTNNB1-positive <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> risks) </plain></SENT>
<SENT sid="5" pm="."><plain>Physical activity level was associated with a lower risk of CTNNB1-negative <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> (multivariate HR = 0.93; 95% CI, 0.87-1.00 for 10 MET-h/wk increment; P = 0.044) but not with CTNNB1-positive <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> risk (multivariate HR = 0.98; 95% CI, 0.91-1.05 for 10 MET-h/wk increment; P = 0.60) </plain></SENT>
<SENT sid="6" pm="."><plain>Our findings argue that <z:hpo ids='HP_0001513'>obesity</z:hpo> and physical inactivity are associated with a higher risk of CTNNB1-negative <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> but not with CTNNB1-positive <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> risk </plain></SENT>
<SENT sid="7" pm="."><plain>Furthermore, they suggest that energy balance and metabolism status exerts its effect in a specific <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> pathway that is less likely dependent on WNT/CTNNB1 activation </plain></SENT>
</text></document>